J
J Adams
Publications - 4
Citations - 149
J Adams is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 109 citations.
Papers
More filters
Journal ArticleDOI
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
Hywel C Williams,Fenella Wojnarowska,Gudula Kirtschig,Gudula Kirtschig,James Mason,Thomas R. Godec,Enno Schmidt,Joanne R Chalmers,Margaret Childs,S. Walton,Karen E. Harman,A. Chapman,Diane Whitham,Andrew J. Nunn,J Adams,V Akhras,Alexander Vincent Anstey,C Barnard,H K Bell,S Blackford,Eva-B. Bröcker,A Carmichael,R.R. Coelho,Fiona Craig,K Davies,Robert Ellis,John C. English,Regine Gläser,Richard Groves,C Günthert,P J Hampton,N. Hepburn,Rainer Hügel,K. Hussain,John R. Ingram,Alison M Layton,Nick J. Levell,V Lewis,H Malhomme,A Omerod,Girish Khandubhai Patel,R Rallan,Jane Ravenscroft,H Santander,Kerstin Steinbrink,Michael Sticherling,C Thomas,M Vatve,N. van Beek,V Venning,Emma Veysey,R. Wachsmuth,Shyamal Wahie,B Walker,M Walsh,J Wee,M Westmoreland,G Wong,Adam Ferguson,Indre Verpetinske,Emilia Duarte-Williamson,Fiona Antony,Chris Bower,David Gawkrodger,Kathy Taghipour,M G S Dunnill,Alex Waters,Walter Bottomley,Andrew M Wright,Jane C. Sterling,Adzura Azam,Sam Gibbs,Thomas A. Luger,Ingrid Salvary,Chris Lovell,Andrew Ilchyshyn,Karen Gibbon,Marinella Nik,Robert Charles-Holmes,A Lloyd Lavery +79 more
TL;DR: Starting patients on doxycycline is non-inferior to standard treatment with oral prednisolone for short-term blister control in bullous pemphigoid and significantly safer in the long-term.
Journal ArticleDOI
In vitro susceptibility of carbapenem resistant Enterobacterales to meropenem-vaborbactam and ceftazidime-avibactam at a single academic medical centre
J Adams,Maressa Santarossa,Amanda T. Harrington,Michael Bauer,A. Wozniak,Laurie Labuszewski,Fritzie S Albarillo +6 more
TL;DR: Carba-R et al. as discussed by the authors performed a retrospective chart review of CRE isolates from 1 January 2016 to 1 November 2018 and collected data including a descriptive overview of measured MIC values, resistance mechanism via a polymerase chain reaction test (PCRT), as well as clinical outcomes.
Journal ArticleDOI
602. Clinical Outcomes of Ertapenem in Patients with Hypoalbuminemia
TL;DR: In this paper , the authors found that in subjects with hypoalbuminemia, treatment with once-daily ertapenem may lead to suboptimal outcomes regarding patient mortality.
Journal ArticleDOI
Antimicrobial Stewardship Techniques for Critically Ill Patients with Pneumonia
J Adams,Kaitlin Ferguson,RaeAnn Hirschy,Erica Konopka,Jordan Meckel,Grace E. Benanti,Shannon Kuhrau,Fritzie S Albarillo,K. Chang,Maressa Santarossa,Julia Sapozhnikov,Brian Hoff,Megan A. Rech +12 more
TL;DR: In this paper , the authors discuss methods to optimize antimicrobial treatment in patients with pneumonia, including the following: procalcitonin use, utilization of methicillin-resistant Staphylococcus aureus nares testing to determine need for vancomycin therapy, and utilization of the Biofire® FilmArray® pneumonia polymerase chain reaction (PCR), and microbiology reporting techniques.